TITLE

Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure

AUTHOR(S)
Zagoura, Dimitra S.; Roubelakis, Maria G.; Bitsika, Vasiliki; Trohatou, Ourania; Pappa, Kalliopi I.; Kapelouzou, Alkistis; Antsaklis, Aristidis; Anagnou, Nicholas P.
PUB. DATE
June 2012
SOURCE
Gut;Jun2012, Vol. 61 Issue 6, p894
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background There is increasing interest in the therapeutic potential of human mesenchymal stem cells (hMSCs), especially in diseases such as acute hepatic failure (AHF) that are predominantly caused by a variety of drugs and viruses. In previous studies, a distinct population termed human spindle-shaped MSCs were isolated and expanded from second trimester amniotic fluid (AF-MSCs) and characterised based on their phenotype, pluripotency and differentiation potential. Methods AF-MSCs, hepatic progenitor-like (HPL) cells and hepatocyte-like (HL) cells derived from AF-MSCs were transplanted into CCl4-injured NOD/SCID mice with the AHF phenotype in order to evaluate their therapeutic potential. Conditioned medium (CM) derived from AF-MSCs or HPL cells was then delivered intrahepatically in order to determine whether the engraftment of the cells or their secreted molecules are the most important agents for liver repair. Results Both HPL cells and AF-MSCs were incorporated into CCl4-injured livers; HPL cell transplantation had a greater therapeutic effect. In contrast, HL cells failed to engraft and contribute to recovery. In addition, HPL-CM was found to be more efficient than CM derived from AFMSCs in treatment of the liver. Proteome profile analysis of HPL-CM indicated the presence of anti-inflammatory factors such as interleukins IL-10, IL-1ra, IL-13 and IL-27 which may induce liver recovery. Blocking studies of IL-10 secretion from HPL cells confirmed the therapeutic significance of this cytokine in the AHF mouse model. Conclusions Human spindle-shaped AF-MSCs or HPL cells might be valuable tools to induce liver repair and support liver function by cell transplantation. More importantly, the factors they release may also play an important role in cell treatment in diseases of the liver. INSET: Significance of this study.
ACCESSION #
76111441

 

Related Articles

  • Implication for Bone Marrow Derived Stem Cells in Hepatocyte Regeneration after Orthotopic Liver Transplantation. Pilat, N.; Unger, L.; Berlakovich, G. A. // International Journal of Hepatology;2013, p1 

    The liver has the outstanding ability to regenerate itself and restore parenchymal tissue after injury. The most common cell source in liver growth/regeneration is replication of preexisting hepatocytes although liver progenitor cells have been postulated to participate in liver regeneration in...

  • Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model. Sun, Haitao; Hou, Zongliu; Yang, Huaqiang; Meng, Mingyao; Li, Peng; Zou, Qingjian; Yang, Lujun; Chen, Yuxin; Chai, Huihui; Zhong, Huilin; Yang, Zara; Zhao, Jing; Lai, Liangxue; Jiang, Xiaodan; Xiao, Zhicheng // Cell & Tissue Research;Sep2014, Vol. 357 Issue 3, p571 

    Amyotrophic lateral sclerosis (ALS) is an adult-onset progressive neurodegenerative disease involving degeneration of motor neurons in the central nervous system. Stem cell treatment is a potential therapy for this fatal disorder. The human amniotic membrane (HAM), an extremely rich and easily...

  • Third-party Mesenchymal Stem Cells Improved Human Islet Transplantation in a Humanized Diabetic Mouse Model. Wu, Hao; Wen, Di; Mahato, Ram I // Molecular Therapy;Sep2013, Vol. 21 Issue 9, p1778 

    Human islet transplantation can be a permanent treatment of type 1 diabetes if the immune rejection and primary nonfunction (PNF) of transplanted islet grafts were properly addressed. In this study, we determined whether cotransplantation of human bone marrow-derived mesenchymal stem cells...

  • Effect of Human Parathyroid Hormone on Hematopoietic Progenitor Cells in NOD/SCID Mice Co-Transplanted with Human Cord Blood Mononuclear Cells and Mesenchymal Stem Cells. Yeon-Jung Lim; Kyoujung Hwang; Miyeon Kim; Youl-Hee Cho; Jong-Hwa Lee; Young-Ho Lee; Jong-Jin Seo // Yonsei Medical Journal;Jan2013, Vol. 54 Issue 1, p238 

    Purpose: We evaluated the effect of human parathyroid hormone (hPTH) on the engraftment and/or in vivo expansion of hematopoietic stem cells in an umbilical cord blood (UCB)-xenotransplantation model. In addition, we assessed its effect on the expression of cell adhesion molecules. Materials and...

  • Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs. Bazhanov, Nikolay; Ylostalo, Joni H.; Bartosh, Thomas J.; Tiblow, April; Mohammadipoor, Arezoo; Foskett, Andrea; Prockop, Darwin J. // Stem Cell Research & Therapy;2/10/2016, Vol. 7, p1 

    Background: Mesenchymal stem/progenitor cells (MSC) have shown beneficial effects in many models of disease in part by modulating excessive inflammatory and immune responses. Frequently the beneficial effects of MSC persist long after their disappearance from host tissues, suggesting that MSC...

  • Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus. Westerweel, Peter E.; Teraa, Martin; Rafii, Shahin; Jaspers, Janneke E.; White, Ian A.; Hooper, Andrea T.; Doevendans, Pieter A.; Verhaar, Marianne C. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Background: Circulating Endothelial Progenitor Cell (EPC) levels are reduced in diabetes mellitus. This may be a consequence of impaired mobilization of EPC from the bone marrow. We hypothesized that under diabetic conditions, mobilization of EPC from the bone marrow to the circulation is...

  • Cell-based therapy for acute and chronic liver failures: Distinct diseases, different choices. Kai Sun; Xuqin Xie; Jing Xie; Shufan Jiao; Xiaojing Chen; Xue Zhao; Xin Wang; Lixin Wei // Scientific Reports;10/3/2014, p1 

    Cell-based therapies (CBTs) are considered the effective approaches to treat liver failure. However, which cell type is the most suitable source of CBTs for acute liver failure (ALF) or chronic liver failure (CLF) remains unclear. To investigate this, mature hepatocytes in adult liver (adult...

  • Osteoblast-Targeted Overexpression of TAZ Increases Bone Mass In Vivo. Yang, Jae-Yeon; Cho, Sun Wook; An, Jee Hyun; Jung, Ju Yeon; Kim, Sang Wan; Kim, Seong Yeon; Kim, Jung Eun; Shin, Chan Soo // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Osteoblasts are derived from mesenchymal progenitors. Differentiation to osteoblasts and adipocytes is reciprocally regulated. Transcriptional coactivator with a PDZ-binding motif (TAZ) is a transcriptional coactivator that induces differentiation of mesenchymal cells into osteoblasts while...

  • De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice. Buttler, Kerstin; Badar, Muhammad; Seiffart, Virginia; Laggies, Sandra; Gross, Gerhard; Wilting, Jörg; Weich, Herbert // Cellular & Molecular Life Sciences;Apr2014, Vol. 71 Issue 8, p1513 

    Cellular pro-angiogenic therapies may be applicable for the treatment of peripheral vascular diseases. Interactions between mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) may provide such a treatment option. With the exception of some studies in man, experiments have only...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics